Novo Nordisk, Evotec Link Around Chronic Kidney Disease

Pair Will Jointly Identify And Develop New CKD Targets

Kidneys
Move underscores Novo Nordisk’s move into adjacent cardio-renal-metabolic areas • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business